JYNT - ジョイント （The Joint Corp.）

The Joint Corp. (NASDAQ:JYNT) price closed lower on Friday, September 02, dropping -5.27% below its previous close. A look at the daily price movement shows that the last close reads $17.82, with intraday deals fluctuated between $16.655 and $18.52. The company’s 5Y monthly beta was ticking 1.34 while its P/E ratio in the trailing 12-month … The Joint Corp. (NASDAQ: JYNT) Shares Rose Recently, But Trouble Could Still Be Around The Corner. Read More »

The Joint Corp. (NASDAQ:NASDAQ:JYNT) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief…

The following slide deck was published by The Joint Corp.

The Joint Corp. posted Q2 FY22 earnings yesterday with upsides in revenue and EPS versus consensus.

https://www.investing.com/news/pro/briley-upgrades-the-joint-corp-to-buy-432SI-2865239

The Joint Corp. posted Q2 FY22 earnings yesterday with upsides in revenue and EPS versus consensus.

https://www.investing.com/news/pro/briley-upgrades-the-joint-corp-to-buy-432SI-2865239

https://www.investing.com/news/pro/maxim-group-upgrades-the-joint-corp-to-buy-432SI-2865238

Joint (NASDAQ: JYNT ) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here''s what investors need to know about the announcement. Earnings Joint beat estimated earnings by 100.0%, reporting an EPS of $0.02 versus an … Full story available on Benzinga.com

- Grew Revenue 24%, System-wide Sales 21%, and System-wide Comp Sales 8% vs. Q2 2021 - - Opened 34 Clinics, Bringing Total Clinics to 769 - - Sold 24 Franchise Licenses, Bringing the Year-to-Date Total to 46 -

Joint (JYNT) acquired four previously owned franchised clinics for $5.8M on May 19, 2022. “This opportunity arose with a multi-unit franchisee with clinics…

Joint (NASDAQ: JYNT ) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 1 2 0 Last 30D 0 0 0 1 0 1M Ago 0 0 1 1 0 2M Ago 0 0 0 0 0 3M Ago 1 0 0 0 0 These 4 analysts have an average price target of $31.25 versus the current price of Joint at $16.575, implying upside. Below is a summary of how these 4 analysts rated Joint over the past 3 months. The greater the number of bullish ratings, the more positive analysts are on the stock and … Full story available on Benzinga.com

The Joint Corp. (NASDAQ:NASDAQ:JYNT) Q1 2022 Earnings Conference Call May 5, 2022 5:00 PM ET Company Participants David Barnard – LHA Investor Relations Peter Holt – President and Chief…

The Joint Corp. (NASDAQ:JYNT)’s traded shares stood at 2.34 million during the latest session, with the company’s beta value hitting 1.28. At the last check today, the stock’s price was $15.85, to imply a decrease of -43.45% or -$12.18 in intraday trading. The JYNT share’s 52-week high remains $111.06, putting it -600.69% down since that … The Joint Corp. (NASDAQ: JYNT) Stock Has Dropped -19.50% Over The Month – Is There Room For Growth? Read More »

ChemoCentryx CCXI +19%. iRhythm Technologies IRTC +16%. Joint JYNT -46%. Endo International ENDP -34%.